Full video transcriptClick to expand
Auto-generated transcript of @paulbakhtiar's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00The best peptides for anxiety would be selenx, max, and oxytocin.
- 0:04The reason why is because they can actually reduce anxiety by really bouncing out neurotransmitters
- 0:08and lowering inflammation in the brain.
- 0:11They help to promote calm focus without sedation.
- 0:13And there's some peptides out there that really help people feel calmer and happier by helping
- 0:17their brain relax.
Peptide therapy TikTok claims: what the science actually supports
Quick answer
Selank and semax have legitimate preliminary research supporting anxiolytic and neuroprotective effects, primarily from Russian clinical literature, but neither is approved for anxiety disorders in the United States or EU. Oxytocin's anxiety effects are bidirectional and context-dependent, making a blanket anxiolytic label inaccurate based on current evidence. Patients considering peptide therapy for anxiety should consult a licensed provider who can assess the limited evidence base, sourcing concerns, and individual risk factors before use.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Peptide therapy TikTok claims: what the science actually supports, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Functional Connectomic Approach to Studying Selank and Semax Effects
Small Russian fMRI study (52 healthy volunteers) of brain connectivity after Semax or Selank; mechanistic and exploratory, not a clinical efficacy trial.
PubMed
Effects of Semax on the Default Mode Network of the Brain
Small human fMRI study (24 adults) of intranasal Semax on brain networks; an imaging-marker study with no clinical outcomes, not replicated outside the originating group.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Peptide therapy TikTok claims: what the science actually supports is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Peptide therapy TikTok claims: what the science actually supports" from Paul Bakhtiar. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Selank and semax have legitimate preliminary research supporting anxiolytic and neuroprotective effects, primarily from Russian clinical literature, but neither is approved for anxiety disorders in the United States or EU.
The reason this review is not generic is the source wording and the canonical claim label "peptides tiktok 7571606468345023774." In this clip, the useful excerpt is: "The best peptides for anxiety would be selenx, max, and oxytocin." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Functional Connectomic Approach to Studying Selank and Semax Effects (2020), Effects of Semax on the Default Mode Network of the Brain (2018), and Therapeutic Peptides: Applications, Challenges, and Future Directions (2026), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Selank and semax have legitimate preliminary research supporting anxiolytic and neuroprotective effects, primarily from Russian clinical literature, but neither is approved for anxiety disorders in the United States or EU.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Selank and semax have legitimate preliminary research supporting anxiolytic and neuroprotective effects, primarily from Russian clinical literature, but neither is approved for anxiety disorders in the United States or EU. Oxytocin's anxiety effects are bidirectional and context-dependent, making a blanket anxiolytic label inaccurate based on current evidence. Patients considering peptide therapy for anxiety should consult a licensed provider who can assess the limited evidence base, sourcing concerns, and individual risk factors before use.
- Selank is the only one of the three with clinical trial data specifically targeting anxiety, and those trials are almost entirely from Russian research institutions with limited independent replication.
- A 2016 review in Trends in Cognitive Sciences found oxytocin can increase anxiety in social threat contexts, directly contradicting the video's claim that it simply helps people feel calmer.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Selank is the only one of the three with clinical trial data specifically targeting anxiety, and those trials are almost entirely from Russian research institutions with limited independent replication.
- A 2016 review in Trends in Cognitive Sciences found oxytocin can increase anxiety in social threat contexts, directly contradicting the video's claim that it simply helps people feel calmer.
- Semax's published human evidence centers on neuroprotection and cognitive function, not anxiety reduction specifically. Calling it an anxiety peptide extrapolates beyond what the literature currently shows.
- None of these three peptides are FDA-approved for any psychiatric indication, including anxiety disorders. They are available primarily as compounded or research-grade products with variable quality control.
- The non-sedating profile of selank is one of its genuinely interesting features compared to benzodiazepines, supported by Semenova et al. (2010), but this should not be interpreted as approval or equivalency to approved treatments.
- Anyone managing a diagnosed anxiety disorder should work with a licensed mental health or medical provider before considering peptide therapy. These compounds do not replace evidence-based treatments.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @paulbakhtiar actually say?
The creator named three peptides as the best options for anxiety: selank, semax, and oxytocin. The reasoning offered was that they "reduce anxiety by really bouncing out neurotransmitters and lowering inflammation in the brain." He also said they "promote calm focus without sedation" and help people feel "calmer and happier by helping their brain relax."
To be fair, he named three peptides that researchers have actually studied in the context of anxiety. That's a better starting point than most peptide content on TikTok, which tends to repeat gym-bro mythology. But the explanation of how they work is vague to the point of being misleading, and the clinical picture is far more complicated than this video lets on.
Does the science back this up?
Partly. Selank has the strongest anxiety-related research, though almost all of it comes from Russian clinical trials. Semax has nootropic and neuroprotective data but thinner anxiety-specific evidence. Oxytocin's relationship with anxiety is genuinely complicated.
Selank is a synthetic analog of tuftsin, and Russian studies including Semenova et al. (2010, Bulletin of Experimental Biology and Medicine) found anxiolytic effects comparable to benzodiazepines in some patients, without sedation or dependence. That part of the video's claim holds up. Semax (an ACTH analog) has been studied for cognitive function and mood, with Dolotov et al. (2006, Journal of Molecular Neuroscience) showing BDNF upregulation, which could indirectly support mood regulation. As for oxytocin, the story is not as clean. Shamay-Tsoory and Abu-Akel (2016, Trends in Cognitive Sciences) documented that oxytocin can actually increase anxiety in certain social contexts and threat environments. Calling it simply an anti-anxiety peptide is an oversimplification the evidence does not support.
What did they get wrong (or right)?
The phrase "bouncing out neurotransmitters" is not a real pharmacological concept, and it deserves to be called out plainly. Selank appears to modulate GABA-A receptors and influence serotonin metabolism. Semax affects dopaminergic and serotonergic pathways. These are specific mechanisms, and dumbing them down to "balancing" does viewers a disservice.
The claim that these peptides lower "inflammation in the brain" is partially supportable for semax, which has shown anti-inflammatory effects in rodent models of brain injury (Gusev et al., 2002, Cerebrovascular Diseases). For selank, there is some cytokine-modulating data. For oxytocin, the anti-inflammatory neurological evidence is thin in humans.
Where the creator deserves credit: selank and semax genuinely do appear to produce anxiolytic or calming effects without the sedation associated with benzodiazepines, based on available data. That distinction is real and worth knowing. But none of these peptides are FDA-approved for anxiety disorders, none have large-scale Phase III human trials in Western regulatory systems, and presenting them as simply "the best peptides for anxiety" skips over all of that.
What should you actually know?
These peptides are not approved treatments for anxiety disorders. If you are managing clinical anxiety, a licensed provider should be your first call, not a TikTok recommendation stack.
Selank and semax are primarily researched in Russia, and most published trials are small, lack independent replication, and were conducted by researchers with institutional ties to the compounds. That does not make the findings false, but it means the evidence base is weaker than the confident tone of videos like this implies. Oxytocin is available as a nasal spray in research settings but its effects on anxiety are context-dependent and not reliably positive across populations.
There are also real practical concerns. These are compounded or research-grade peptides in most Western markets. Quality control varies significantly between suppliers. Dosing, administration method, and individual neurochemistry all affect outcomes in ways a short video cannot address.
- Selank: most promising anxiety data, but almost exclusively from Russian trials
- Semax: stronger nootropic than anxiolytic evidence in current literature
- Oxytocin: bidirectional anxiety effects depending on context, not a simple calming agent
- None are FDA-approved for psychiatric indications
- "Calm focus without sedation" is a reasonable characterization for selank specifically, less so for the others
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Paul Bakhtiar · TikTok creator
13.9K views on this video
Peptide therapy TikTok claims: what the science actually supports
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about selank?
Selank is the only one of the three with clinical trial data specifically targeting anxiety, and those trials are almost entirely from Russian research institutions with limited independent replication.
What does the video say about a 2016 review in trends in cognitive sciences found oxytocin?
A 2016 review in Trends in Cognitive Sciences found oxytocin can increase anxiety in social threat contexts, directly contradicting the video's claim that it simply helps people feel calmer.
What does the video say about semax's published human evidence centers on neuroprotection?
Semax's published human evidence centers on neuroprotection and cognitive function, not anxiety reduction specifically. Calling it an anxiety peptide extrapolates beyond what the literature currently shows.
What does the video say about none of these three peptides?
None of these three peptides are FDA-approved for any psychiatric indication, including anxiety disorders. They are available primarily as compounded or research-grade products with variable quality control.
What does the video say about the non-sedating profile of selank?
The non-sedating profile of selank is one of its genuinely interesting features compared to benzodiazepines, supported by Semenova et al. (2010), but this should not be interpreted as approval or equivalency to approved treatments.
What does the video say about anyone managing a diagnosed anxiety disorder should work with a?
Anyone managing a diagnosed anxiety disorder should work with a licensed mental health or medical provider before considering peptide therapy. These compounds do not replace evidence-based treatments.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Paul Bakhtiar, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.